Journal: Nanomaterials

Article Title: PLATOX: Integrated In Vitro/In Vivo Approach for Screening of Adverse Lung Effects of Graphene-Related 2D Nanomaterials

doi: 10.3390/nano12081254

Figure Lengend Snippet: GRNP dispersions. Left: Light microscopic pictures of the different GRNP (P1–P8) dispersions at 6.25 µg/mL corresponding to the lowest concentration used for in vitro screening (3.125 µg/cm 2 ). Right: Sedimentation kinetics for the various GRNP (P1–P8) at 6.25 µg/mL. GRNP dispersions were placed in semi-micro cuvettes and turbidity (OD600) was measured directly after material suspension (time point zero) and after 1, 18, 24 and 48 h of incubation at 37 °C in a water saturation atmosphere using an incubator. OD600 at time point zero was set to 100% and relative turbidity was calculated for the other time points. Data represent the means ± SD of three independent experiments.

Article Snippet: Six GRNP samples, including three functionalized materials, were purchased from ACS Material, LLC (Medford, MA, USA).

Techniques: Concentration Assay, In Vitro, Sedimentation, Suspension, Incubation

Journal: Nanomaterials

Article Title: PLATOX: Integrated In Vitro/In Vivo Approach for Screening of Adverse Lung Effects of Graphene-Related 2D Nanomaterials

doi: 10.3390/nano12081254

Figure Lengend Snippet: GRNP-related histopathological findings at day 1 post-exposure.

Article Snippet: Six GRNP samples, including three functionalized materials, were purchased from ACS Material, LLC (Medford, MA, USA).

Techniques:

Journal: Nanomaterials

Article Title: PLATOX: Integrated In Vitro/In Vivo Approach for Screening of Adverse Lung Effects of Graphene-Related 2D Nanomaterials

doi: 10.3390/nano12081254

Figure Lengend Snippet: GRNP-related histopathological findings at day 29 post-exposure.

Article Snippet: Six GRNP samples, including three functionalized materials, were purchased from ACS Material, LLC (Medford, MA, USA).

Techniques: